| JYHZ2200151 | 拉莫三嗪分散片 | lamotrigine | Tablet | Chemical Drugs | License Renew | 2022-06-17 | | GlaxoSmithKline (China) Investment Co Ltd;The Wellcome Foundation Ltd;GlaxoSmithKline Phaemaceuticals SA | | | view |
| JYHZ2200150 | 拉莫三嗪分散片 | lamotrigine | Tablet | Chemical Drugs(5.1) | License Renew | 2022-06-17 | | GlaxoSmithKline (China) Investment Co Ltd;The Wellcome Foundation Ltd;GlaxoSmithKline Phaemaceuticals SA | | | view |
| JYHZ2200149 | 拉莫三嗪分散片 | lamotrigine | Tablet | Chemical Drugs(5.1) | License Renew | 2022-06-17 | | GlaxoSmithKline (China) Investment Co Ltd;The Wellcome Foundation Ltd;GlaxoSmithKline Phaemaceuticals SA | | | view |
| JYHZ2200148 | 拉莫三嗪分散片 | lamotrigine | Tablet | Chemical Drugs(5.1) | License Renew | 2022-06-17 | | GlaxoSmithKline (China) Investment Co Ltd;The Wellcome Foundation Ltd;GlaxoSmithKline Phaemaceuticals SA | | | view |
| JYHZ2200147 | 拉莫三嗪分散片 | lamotrigine | Tablet | Chemical Drugs(5.1) | License Renew | 2022-06-17 | | GlaxoSmithKline (China) Investment Co Ltd;The Wellcome Foundation Ltd;GlaxoSmithKline Phaemaceuticals SA | | | view |
| JYHZ1700012 | 拉莫三嗪分散片 | lamotrigine | Tablet | Chemical Drugs | License Renew | 2017-07-26 | 泰卫医药信息咨询（上海）有限公司 | Teva Pharmaceutical Information Consulting (Shanghai) Co Ltd;Actavis Group Ptc Ehf | Certificate Issued | 2018-07-19 | view |
| JYHZ1700011 | 拉莫三嗪分散片 | lamotrigine | Tablet | Chemical Drugs | License Renew | 2017-08-03 | 泰卫医药信息咨询（上海）有限公司 | Teva Pharmaceutical Information Consulting (Shanghai) Co Ltd;Actavis Group Ptc Ehf | Certificate Issued | 2018-07-19 | view |
| JYHB2500228 | 拉莫三嗪分散片 | lamotrigine | Tablet | Chemical Drugs | Supplementary Application | 2025-04-19 | | The Wellcome Foundation Ltd;Delpharm Poznan SA | | | view |
| JYHB2400625 | 拉莫三嗪分散片 | lamotrigine | Tablet | Chemical Drugs | Supplementary Application | 2024-11-30 | | The Wellcome Foundation Ltd;Delpharm Poznan SA | | | view |
| JYHB2400624 | 拉莫三嗪分散片 | lamotrigine | Tablet | Chemical Drugs | Supplementary Application | 2024-11-30 | | The Wellcome Foundation Ltd;Delpharm Poznan SA | | | view |
| JYHB2400623 | 拉莫三嗪分散片 | lamotrigine | Tablet | Chemical Drugs | Supplementary Application | 2024-11-30 | | The Wellcome Foundation Ltd;Delpharm Poznan SA | | | view |
| JYHB2400622 | 拉莫三嗪分散片 | lamotrigine | Tablet | Chemical Drugs | Supplementary Application | 2024-11-30 | | The Wellcome Foundation Ltd;Delpharm Poznan SA | | | view |
| JYHB2400621 | 拉莫三嗪分散片 | lamotrigine | Tablet | Chemical Drugs | Supplementary Application | 2024-11-30 | | The Wellcome Foundation Ltd;Delpharm Poznan SA | | | view |
| JYHB2101195 | 拉莫三嗪分散片 | lamotrigine | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2021-06-21 | | The Wellcome Foundation Ltd;GlaxoSmithKline Phaemaceuticals SA | | | view |
| JYHB2101194 | 拉莫三嗪分散片 | lamotrigine | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2021-06-21 | | The Wellcome Foundation Ltd;GlaxoSmithKline Phaemaceuticals SA | | | view |
| JYHB2101193 | 拉莫三嗪分散片 | lamotrigine | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2021-06-21 | | The Wellcome Foundation Ltd;GlaxoSmithKline Phaemaceuticals SA | | | view |
| JYHB2101192 | 拉莫三嗪分散片 | lamotrigine | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2021-06-21 | | The Wellcome Foundation Ltd;GlaxoSmithKline Phaemaceuticals SA | | | view |
| JYHB2101191 | 拉莫三嗪分散片 | lamotrigine | Tablet | Chemical Drugs | Supplementary Application | 2021-06-21 | | The Wellcome Foundation Ltd;GlaxoSmithKline Phaemaceuticals SA | | | view |
| JYHB2101076 | 拉莫三嗪分散片 | lamotrigine | Tablet | Chemical Drugs | Supplementary Application | 2021-04-30 | | The Wellcome Foundation Ltd;GlaxoSmithKline Phaemaceuticals SA | | | view |
| JYHB2001654 | 拉莫三嗪分散片 | lamotrigine | Tablet | Chemical Drugs | Supplementary Application | 2020-09-02 | 哈药集团医药有限公司 | HPGC Pharmaceutical Co Ltd;Actavis Group Ptc Ehf;Specifar SA | In Review | 2020-09-01 | view |
